Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 topical spray in mild to moderate atopic dermatitis
NCT03235024Phase 2Completed
- Sponsor
- AOBiome
- Start
- Jan 2018
- Primary completion
- Feb 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing B244 with Vehicle (2 arms). Primary endpoint: Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 at Day 42. Started Jan 2018; status: completed.
02
Drugs
B244
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03235024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03235024.